Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Neurology|March 1, 1995
Dopamine agonists in Parkinson's diseaseE C Wolters, G Tissingh, P L Bergmans, et al.Journal of the Neurological Sciences|July 1, 1993
Whole blood monoamine oxidase activity in Parkinson's disease and multiple system atrophy patientsM A Kuiper, C H Konings, P L Bergmans, et al.Neurology|October 1, 1996
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's diseaseE C Wolters, E N Jansen, H G Tuynman-Qua, et al.Journal of the Neurological Sciences|January 1, 1994
Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patientsM A Kuiper, J J Visser, P L Bergmans, et al.Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's diseaseM A Kuiper, G J van Kamp, P L Bergmans, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|June 10, 2000
L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patientsM A Kuiper, T Teerlink, J J Visser, et al.Annals of Neurology|July 18, 2001
Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smellH W Berendse, J Booij, C M Francot, et al.Pageof 1